3rd Quarter - Report

THORN RUN PARTNERS for SUNOVION PHARMACEUTICALS INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

DEA scheduling of pharmaceuticals

LobbyistCovered position, as disclosed
CATHERINE FINLEY —
GARY PALMQUIST —
BILLY WYNNE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Veterans VET

Funding issues related to the VA Epilepsy Centers for Excellence.

LobbyistCovered position, as disclosed
CATHERINE FINLEY —
GARY PALMQUIST —
BILLY WYNNE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017. Medicare Part D, Medicaid reform, mental and neurological health issues.

LobbyistCovered position, as disclosed
CATHERINE FINLEY —
GARY PALMQUIST —
BILLY WYNNE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1628 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.